CA
CELG

Commerzbank Aktiengesellschaft’s Celgene Corp CELG Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-199,100
Closed -$1.41M – 1077
2019
Q2 		$1.41M Buy
199,100
+119,100
+149% +$11.3M 0.01% 536
2019
Q1 		$59K Sell
80,000
-131,300
-62% -$11.5M ﹤0.01% 838
2018
Q4 		$3.44M Buy
211,300
+159,400
+307% +$11.8M 0.04% 320
2018
Q3 		$413K Buy
+51,900
New +$4.59M ﹤0.01% 724
2015
Q3 		– Sell
-45,000
Closed -$5.21M – 1242
2015
Q2 		$5.21M Sell
45,000
-8,100
-15% -$926K 0.03% 356
2015
Q1 		$6.12M Sell
53,100
-45,000
-46% -$5.38M 0.04% 327
2014
Q4 		$11M Buy
98,100
+88,000
+871% +$9.28M 0.07% 245
2014
Q3 		$957K Buy
+10,100
New +$911K ﹤0.01% 851

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Commerzbank Aktiengesellschaft's CELG Position: Q4 2019 in Review

Commerzbank Aktiengesellschaft sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 349,448 shares — an estimated $34.7M sold.

Commerzbank Aktiengesellschaft first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $85.1M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Commerzbank Aktiengesellschaft reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 349,448 Celgene Corp shares in Q4 2019, an estimated $34.7M.
  • Commerzbank Aktiengesellschaft first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Commerzbank Aktiengesellschaft's Celgene Corp position peaked at $85.1M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q4 2019, filed 17 Jan 2020.